Special Drug Use-results Surveillance of Tafinlar/Mekinist

Clinical trial NCT06262919 · RECRUITING

Trial details

NCT number: NCT06262919
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

BRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid Tumor

Start date: 2024-02-09
Primary completion: 2031-12-31
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.